PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.
复制标题

DOI:
10.1136/bmj.n160
复制
发表时间:
2021-03-29
期刊:
BMJ (Clinical research ed.)
影响因子:
--
通讯作者:
McKenzie JE
McKenzie JE
中科院分区:
其他
文献类型:
--
作者:
Page MJ;Moher D;Bossuyt PM;Boutron I;Hoffmann TC;Mulrow CD;Shamseer L;Tetzlaff JM;Akl EA;Brennan SE;Chou R;Glanville J;Grimshaw JM;Hróbjartsson A;Lalu MM;Li T;Loder EW;Mayo-Wilson E;McDonald S;McGuinness LA;Stewart LA;Thomas J;Tricco AC;Welch VA;Whiting P;McKenzie JE

文献摘要

被引文献

相似文献

系统性综述的方法和结果应报告得足够详细,以便使用者能够评估综述结果的可信度和适用性。系统性综述和荟萃分析的首选报告项目(PRISMA)声明旨在促进系统性综述的透明和完整报告,并已更新(至PRISMA 2020),以反映系统性综述方法和术语的最新进展。在这里,我们提出了PRISMA 2020的解释和阐述文件,其中我们解释了为什么建议报告每个项目,提出了详细报告建议的要点,并从已发表的评论中提供了示例。我们希望PRISMA 2020的内容和结构的变化将促进该指南的采用,并导致系统评价的报告更加透明,完整和准确。
The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.